ATOMIC-Meso: A randomized phase 2/3 trial of ADI-PEG2O or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma Meeting Abstract
| Authors: | Wojciech Szlosarek, P.; Baas, P.; Ceresoli, G. L.; Fennell, D. A.; Gilligan, D.; Johnston, A.; Lee, P.; Mansfield, A. S.; Nolan, L.; Nowak, A. K.; Steele, J. P. C.; Taylor, P.; Tsao, A. S.; Zauderer, M. G.; Bomalaski, J. S. |
| Abstract Title: | ATOMIC-Meso: A randomized phase 2/3 trial of ADI-PEG2O or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 446s |
| Language: | English |
| ACCESSION: | WOS:000411932201159 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS8582 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS8582 -- Source: Wos |
